You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antisecretory factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Lund (Salovum, Placebo egg yolk powder)

Recruiting
  • Glioblastoma
  • Salovum
  • Placebo egg yolk powder
  • Lund, Sweden
    Skåne University Hospital
Dec 30, 2022

Brain Trauma Trial in Cape Town (Salovum, Placebo)

Recruiting
  • Brain Trauma
  • Salovum
  • Placebo
  • Cape Town, South Africa
    Department of Neurosurgery, Tygerberg Hospital, Francie Van Zijl
Oct 11, 2021

Anal Cancer Trial (Salovum and SPC-flakes or corresponding )

Not yet recruiting
  • Anal Cancer
  • Salovum and SPC-flakes or corresponding placebo
  • (no location specified)
Apr 22, 2022

Glioblastoma, Cerebral Edema, Chemo Effect Trial in Lund (Salovum)

Completed
  • Glioblastoma
  • +2 more
  • Salovum
  • Lund, Sweden
    Department of Neurosurgery
Apr 27, 2021

Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer Trial in Uppsala (Salovum and SPC-flakes active or )

Recruiting
  • Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer
  • Salovum and SPC-flakes active or placebo
  • Uppsala, Sweden
    University hospital
May 18, 2022

Glaucoma Trial in Stockholm (Salovum, Placebo)

Terminated
  • Glaucoma
  • Salovum
  • Placebo
  • Stockholm, Sweden
    St Erik Eye Hospital
May 11, 2021

Early-stage Breast Cancer, Diarrhea, Adverse Drug Event Trial in Sweden (SPC-flakes, Salovum, Placebo)

Recruiting
  • Early-stage Breast Cancer
  • +2 more
  • Eskilstuna, Sweden
  • +6 more
Nov 28, 2023

Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

Active, not recruiting
  • Well Differentiated Pancreatic Endocrine Tumor
  • Everolimus plus Octreotide LAR plus Metformin
  • Milano, Italy
    Fondazione IRCCS Istituto Tumori Milano
Sep 3, 2021

HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Helicobacter Pylori Infection Trial in Zagazig (Black Seed Oil Cap/Tab, Vonoprazan, Amoxicillin and Clarithromycin)

Not yet recruiting
  • Helicobacter Pylori Infection
  • Black Seed Oil Cap/Tab
  • Vonoprazan, Amoxicillin and Clarithromycin
  • Zagazig, Egypt
    GIT department zagazig university hospital
Jul 14, 2023

Cancer Therapy-Related Diarrhea, Chemo-related Diarrhea, Adult Solid Tumor Trial in United States (Crofelemer 125 MG [Mytesi],

Recruiting
  • Cancer Therapy-Related Diarrhea
  • +5 more
  • Crofelemer 125 MG [Mytesi]
  • Placebo
  • Corona, California
  • +13 more
May 2, 2022

Severe Hemophilia A Trial in China (FRSW117)

Not yet recruiting
  • Severe Hemophilia A
  • Beijing, China
  • +27 more
Nov 16, 2023

Factor XIII Activity in Gastrointestinal Bleedings

Active, not recruiting
  • Gastro Intestinal Bleeding
  • Factor XIII Injection
  • Graz, Styria, Austria
    Medical University of Graz
Jul 4, 2023

Evaluation of Risk Factors and Outcome of Thrombosis in Children

Not yet recruiting
  • Thrombosis in Children
  • complete blood count
  • Sohag, Egypt
    Sohag University hospitals
Apr 30, 2023

Patients With End Stage Liver Disease

Not yet recruiting
  • Liver Cirrhosis
  • +6 more
    • Palo Alto, California
      Stanford Hospital
    Aug 23, 2023

    Osteoarthritis Knee, Corticosteroid, Platelet Rich Plasma Trial (Corticosteroid, Platelet Rich Plasma)

    Not yet recruiting
    • Osteoarthritis Knee
    • +2 more
    • (no location specified)
    Feb 21, 2023

    Serum Insulin-like Growth Factor Binding Protein-3 asPotential

    Not yet recruiting
    • Colorectal Cancer
    • evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
    • (no location specified)
    May 6, 2023

    Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

    Not yet recruiting
    • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
    • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 13, 2022

    Tooth Extraction, Immediate Implant Placement Trial in Iowa City (Xenogeneic Volume-Stable Collagen (VCMX) graft with growth

    Not yet recruiting
    • Tooth Extraction
    • Immediate Implant Placement
    • Xenogeneic Volume-Stable Collagen (VCMX) graft with growth factor-BB
    • Iowa City, Iowa
      University of Iowa College of Dentistry and Dental Clinics
    Sep 8, 2023

    In Vitro Fertilization, ICSI Intracytoplasmic Spermatozoid Injection Trial in Bondy (Ovulation induction with hCG + Luteal phase

    Not yet recruiting
    • In Vitro Fertilization
    • ICSI Intracytoplasmic Spermatozoid Injection
    • Ovulation induction with hCG + Luteal phase support with vaginal progesterone
    • Ovulation triggering by Triptorelin + Luteal phase support by Nafarelin
    • Bondy, France
      Maeliss Peigné
    Nov 27, 2023

    Hemophilia A Trial in Worldwide (BAY2599023 (DTX201))

    Active, not recruiting
    • Hemophilia A
    • BAY2599023 (DTX201)
    • Little Rock, Arkansas
    • +12 more
    Jan 5, 2023

    Hemophilia Trial (Coagulation Factor VIIa (Recombinant))

    Not yet recruiting
    • Hemophilia
    • Coagulation Factor VIIa (Recombinant)
    • (no location specified)
    Jan 12, 2023

    Health Care Interventions and Outcomes of Major Bleedings in

    Not yet recruiting
    • Major Bleeding
    • None (Observational study)
    • (no location specified)
    Nov 17, 2023

    Gastric Cancer Trial in Goyang (CKD-702 in combination with irinotecan)

    Recruiting
    • Gastric Cancer
    • CKD-702 in combination with irinotecan
    • Goyang, Gyeonggi, Korea, Republic of
      National Cancer Center
    Feb 20, 2023

    Hemophilia A Trial (Nuwiq)

    Not yet recruiting
    • Hemophilia A
    • (no location specified)
    Jul 3, 2023